Compugen (CGEN) Current Deferred Tax Assets (2019 - 2026)
Compugen (CGEN) posted quarterly Current Deferred Tax Assets of $2.5 million for Q1 2026, down 9.89% year-over-year from $2.8 million in Q1 2025, and down 1.39% on a QoQ basis from $2.5 million in Q4 2025.
Analysis
Compugen (CGEN) Current Deferred Tax Assets (2019 - 2026) Analysis & Trends
Compugen has reported Current Deferred Tax Assets for 8 years, with the latest figure at $2.5 million in Q1 2026.
- Current Deferred Tax Assets for Q1 2026 came in at $2.5 million, down 9.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.5 million (down 9.89% YoY), and the FY2025 annual result was $2.5 million, down 11.33% from the prior year.
- Current Deferred Tax Assets fell to $2.5 million in Q1 2026, from $2.5 million in the prior quarter.
- Over five years, Current Deferred Tax Assets peaked at $3.1 million in Q1 2024 and troughed at $1.3 million in Q4 2023.
- A 5-year average of $2.3 million and a median of $2.5 million in 2026 frame the typical range for Current Deferred Tax Assets.
- The widest annual swing landed in 2023, when Current Deferred Tax Assets declined 27.22%; it then soared 113.92% in 2024.
- A 5-year view of Current Deferred Tax Assets shows it stood at $1.8 million in 2022, then declined by 27.22% to $1.3 million in 2023, then soared by 113.92% to $2.8 million in 2024, then fell by 11.33% to $2.5 million in 2025, then declined by 1.39% to $2.5 million in 2026.
- Per Business Quant data, the three most recent Current Deferred Tax Assets figures were $2.5 million in Q1 2026, $2.5 million in Q4 2025, and $2.6 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Compugen | 242.44 Mn | 156.82 Mn | -92,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.42 Mn |
| Mar 31, 2026 | 2.49 Mn |
| Dec 31, 2025 | 2.52 Mn |
| Sep 30, 2025 | 2.60 Mn |
| Jun 30, 2025 | 2.68 Mn |
| Mar 31, 2025 | 2.76 Mn |
| Dec 31, 2024 | 2.84 Mn |
| Sep 30, 2024 | 2.95 Mn |
| Jun 30, 2024 | 3.06 Mn |
| Mar 31, 2024 | 3.08 Mn |
| Dec 31, 2023 | 1.33 Mn |
| Sep 30, 2023 | 1.43 Mn |
| Jun 30, 2023 | 1.61 Mn |
| Mar 31, 2023 | 1.75 Mn |
| Dec 31, 2022 | 1.83 Mn |
| Sep 30, 2022 | 1.86 Mn |
| Jun 30, 2022 | 1.95 Mn |
| Mar 31, 2022 | 2.12 Mn |
| Dec 31, 2021 | 2.25 Mn |
| Sep 30, 2021 | 2.35 Mn |